Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
Novavax said the deal with Sanofi allows it to remove its "going concern" warning, which it first issued last year
Read MoreNovavax said the deal with Sanofi allows it to remove its "going concern" warning, which it first issued last year
Read MoreThe deal will allow Novavax to lift its "going concern" warning, which it first issued in 2023 due to having
Read MoreOver the last 12 months, just 11 stocks made up half of the gains that powered the pan-European Stoxx 600
Read MoreThe CEOs of Merck, Johnson & Johnson and Bristol Myers Squibb will testify at the hearing on drug prices, Sen.
Read MoreThe JPMorgan Healthcare Conference was likely just the beginning of another year of heightened interest and investments in ADC cancer
Read MoreDrugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the United States on more than 500 unique
Read MoreBefore successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures
Read MoreThe CDC's move to increase availability of Beyfortus, a monoclonal antibody from Sanofi and AstraZeneca, comes as RSV cases rise
Read MoreBank of America's list of top European picks includes stocks ranging from Mercedes-Benz to GSK, and Shell to LVMH. Source
Read More